Notice2023-09063
Healthcare Infection Control Practices Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 1, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This virtual meeting is open to the public, limited only by room seating available (120). The public is also welcomed to listen to the meeting via Zoom; 500 teleconference lines are available. Time will be available for public comment. Registration is required.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 83 (Monday, May 1, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 83 (Monday, May 1, 2023)]
[Notices]
[Pages 26547-26548]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-09063]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Healthcare Infection Control Practices Advisory Committee
(HICPAC). This virtual meeting is open to the public, limited only by
room seating available (120). The public is also welcomed to listen to
the meeting via Zoom; 500 teleconference lines are available. Time will
be available for public comment. Registration is required.
DATES: The meeting will be held on June 8, 2023, 9 a.m. to 5 p.m., EDT,
and June 9, 2023, 9 a.m. to 12 p.m., EDT.
ADDRESSES: Registration is required to attend in person or on the
phone. Interested parties must be processed in accordance with
established federal policies and procedures and may
[[Page 26548]]
register at <a href="https://www.cdc.gov/hicpac">https://www.cdc.gov/hicpac</a>. All registered participants
will receive instructions shortly before the meeting. Please click
first link for day one and the second link for day two to join the
webinar:
<a href="https://cdc.zoomgov.com/j/1616828862?pwd=N3hmSTEvQjQ3ZHFScVMyM1k2Mk8yUT09">https://cdc.zoomgov.com/j/1616828862?pwd=N3hmSTEvQjQ3ZHFScVMyM1k2Mk8yUT09</a>.
Meeting ID: 161 682 8862.
Passcode: 74249065.
<a href="https://cdc.zoomgov.com/j/1614944394?pwd=UWdBRDNNK2pDdS9PMjlMZzYvRVFzZz09">https://cdc.zoomgov.com/j/1614944394?pwd=UWdBRDNNK2pDdS9PMjlMZzYvRVFzZz09</a>.
Meeting ID: 161 494 4394.
Passcode: 26658671.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention, l600 Clifton Road NE, Mailstop H16-
3, Atlanta, Georgia 30329. Telephone (404) 718-8039; Email:
<a href="/cdn-cgi/l/email-protection#85edece6f5e4e6c5e6e1e6abe2eaf3"><span class="__cf_email__" data-cfemail="9bf3f2f8ebfaf8dbf8fff8b5fcf4ed">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion, the
Director, NCEZID, the Director, CDC, and the Secretary, Health and
Human Services, regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include updates on CDC's
activities for prevention of healthcare-associated infections. It will
also include updates from the following HICPAC workgroups: the
Isolation Precautions Guideline workgroup, the Dental Unit Waterline
Guideline Workgroup, the Healthcare Personnel Guideline Workgroup, the
Neonatal Intensive Care Unit Guideline Workgroup, and the National
Healthcare Safety Network Workgroup. The agenda also includes updates
on CDC and DHQP activities. Agenda items are subject to change as
priorities dictate.
Public Participation
Oral Public Comment: Time will be available for public comment.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated,
following the last call for comments.
Written Public Comment: The public is welcomed to submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed above. The deadline for
receipt of written public comment is May 26, 2023. All requests must
contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length and delivered in 3
minutes or less. Written comments received in advance of the meeting
will be included in the official record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-09063 Filed 4-28-23; 8:45 am]
BILLING CODE 4163-19-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 1, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.